ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
₹1,113.90
arrow_downward
-0.81%(-9.10) 1D
Okt 19, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ZYDUSLIFE...
Buksan
₹1,116.40
Mataas
₹1,134.20
Mababa
₹1,110.30
Mkt. cap
1.11T
Avg. na dami
1.50M
Dami
253.45K
Dividend
0.09%
Bawat tatlong buwang dividend
₹0.25
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
24.83
Mataas nang 52-wk
₹1,232.10
Mababa nang 52-wk
₹835.50
EPS
₹44.87
Bilang ng mga empleyado
30K
Buksan
₹1,116.40
Mataas
₹1,134.20
Mababa
₹1,110.30
Mkt. cap
1.11T
Avg. na dami
1.50M
Dami
253.45K
Dividend
0.09%
Bawat tatlong buwang dividend
₹0.25
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
24.83
Mataas nang 52-wk
₹1,232.10
Mababa nang 52-wk
₹835.50
EPS
₹44.87
Bilang ng mga empleyado
30K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Bloomberg.com
·
6 oras ang nakalipas
US Futures Climb With Semiconductor Stocks Rebounding After Rout
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
FXStreet
·
4 araw ang nakalipas
Dow Jones futures gains ahead of US PPI, Retail Sales data
Barron's
·
4 araw ang nakalipas
The S&P 500’s Dividend Yield Is at an All-Time Low. Is That a Bad Sign?
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
Tungkol sa Zydus Lifesciences Ltd